nirmatrelvir and Chemical-and-Drug-Induced-Liver-Injury

nirmatrelvir has been researched along with Chemical-and-Drug-Induced-Liver-Injury* in 2 studies

Other Studies

2 other study(ies) available for nirmatrelvir and Chemical-and-Drug-Induced-Liver-Injury

ArticleYear
Minimal Risk of Drug-Induced Liver Injury With Molnupiravir and Ritonavir-Boosted Nirmatrelvir.
    Gastroenterology, 2023, Volume: 164, Issue:1

    Topics: Antiviral Agents; Chemical and Drug Induced Liver Injury; Humans; Hydroxylamines; Ritonavir

2023
Drug-induced Liver Injury With Ritonavir-Boosted Nirmatrelvir: Evidence From Coronavirus Disease 2019 Emergency Use Authorization Adverse Event Reporting System.
    Gastroenterology, 2023, Volume: 165, Issue:1

    Topics: Antiviral Agents; Chemical and Drug Induced Liver Injury; COVID-19; COVID-19 Drug Treatment; Humans; Ritonavir

2023